Cost-effectiveness analysis of pharmacogenomics (PGx)-based warfarin, apixaban, and rivaroxaban versus standard warfarin for the management of atrial fibrillation …
Objective To assess the cost-effectiveness of pharmacogenomics (PGx)-based warfarin (ie,
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …
warfarin dosing following genetic testing), apixaban, and rivaroxaban oral anticoagulation …
[PDF][PDF] Novel anticoagulants in the management of atrial fibrillation: A comprehensive comparative analysis
MM Jwaid, MJ Alwan, I Ihsan, MM Jwaid… - …, 2024 - pharmacia.pensoft.net
Background: Atrial fibrillation (AF) stands as the most prevalent cardiac arrhythmia, with
associated risks of stroke and systemic thromboembolism. While vitamin K antagonists …
associated risks of stroke and systemic thromboembolism. While vitamin K antagonists …